Keyphrases
Fibulin-3
100%
Destabilizing Domain
88%
EFEMP1
66%
Methylenetetrahydrofolate Reductase (MTHFR)
66%
Escherichia Coli
33%
In Vivo Evaluation
33%
Genetic Pathways
33%
Liver
33%
Pharmacological Chaperone
33%
Simultaneous Control
33%
Loss Function
33%
Extracellular Matrix Organization
33%
Disulfide
33%
Homodimer
33%
Cysteine mutant
33%
Age-related
33%
Retinal Integrity
33%
Retinal Degeneration
33%
Mouse Model
33%
Retinal Aging
33%
Knock-in Mouse Model
33%
Retinal pigment Epithelium
29%
Extracellular Matrix
25%
Protein of Interest
25%
Ocular Tissues
24%
Stabilizer
22%
Hepatic Tissue
19%
Small Molecules
16%
Protein Abundance
14%
Remodeling Enzymes
11%
Extracellular Matrix Remodeling
11%
Matrix metalloproteinase-2 (MMP-2)
11%
Domain-independent
11%
In Vivo Mice
11%
Aged Mice
8%
Drosophilidae
8%
Caenorhabditis Elegans
8%
Quaternary Functions
8%
Worm
8%
Tissue Integrity
8%
Cysteine Modification
8%
Cysteine
8%
Quaternary Structure
8%
Surface Glycoprotein
8%
Connective Tissue
8%
Autosomal Recessive
8%
Reintroduction
8%
Collagen VI
8%
Overexpression
8%
Marfan Syndrome
8%
Biochemistry, Genetics and Molecular Biology
Dihydrofolate Reductase
66%
Mouse
61%
Escherichia coli
38%
Disulfide
33%
Mouse Model
33%
Genetics
33%
Protein Domain
33%
Cysteine
33%
Small Molecule
33%
Target Tissue
33%
Pharmacological Chaperone
33%
Fibulin
33%
Caenorhabditis Elegans
16%
Wild Type
13%
Collagen VI
6%
Protein Quaternary Structure
6%
Marfan's Syndrome
6%
Autosomal Recessive Inheritance
6%
Secretion (Process)
6%
Enzyme
6%
Glycoprotein
6%
Gelatinase A
6%
MMP2
6%
Genetic Model
5%
Gene Therapy
5%
Trimethoprim
5%
Chymotrypsin
5%
Neuroscience
Dihydrofolate Reductase
66%
Fibulin
66%
In Vivo
44%
Protein Domain
33%
Retinal Degeneration
33%
Retinal Pigment Epithelium
18%
Caenorhabditis Elegans
16%
In Vitro
11%
Staining Technique
9%
Ophthalmic Disorder
8%
Extracellular Matrix
7%
Trimethoprim
5%
Eye
5%
Chymotrypsin
5%
Cornea
5%
